| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 246 | 2.791 | 2.584 | 975 | 1.072 | 6.082 |
| Total Income - EUR | - | - | - | - | 7.476 | 12.918 | 4.551 | 2.835 | 2.550 | 7.338 |
| Total Expenses - EUR | - | - | - | - | 9.542 | 17.036 | 12.088 | 11.587 | 11.103 | 8.252 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.066 | -4.118 | -7.536 | -8.751 | -8.553 | -914 |
| Net Profit/Loss - EUR | - | - | - | - | -2.069 | -4.146 | -7.602 | -8.781 | -8.961 | -2.088 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ldn Ribonucleic Caffe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 6.401 | 6.911 | 4.828 | 2.982 | 1.495 | 230 |
| Current Assets | - | - | - | - | 15.621 | 7.634 | 7.535 | 638 | 1.334 | 1.638 |
| Inventories | - | - | - | - | 944 | 720 | 600 | 621 | 1.256 | 1.661 |
| Receivables | - | - | - | - | 7.047 | 6.913 | 6.870 | 0 | 0 | 0 |
| Cash | - | - | - | - | 7.631 | 1 | 66 | 17 | 78 | -23 |
| Shareholders Funds | - | - | - | - | -2.026 | -6.134 | -13.600 | -22.423 | -31.315 | -33.229 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.086 | 10.121 | 17.569 | 23.060 | 32.650 | 34.867 |
| Income in Advance | - | - | - | - | 20.962 | 10.558 | 8.394 | 2.982 | 1.495 | 230 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Ldn Ribonucleic Caffe S.r.l.